We are live on ! Find out more
RJT

Raymond James Trust Portfolio holdings

AUM $4.6B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+2.5%
1 Year Est. Return
+33.54%
3 Year Est. Return
+41.33%
5 Year Est. Return
+111.23%
10 Year Est. Return
+235.1%
AUM
$1.94B
AUM Growth
+$124M
Cap. Flow
+$90M
Cap. Flow %
4.64%
Top 10 Hldgs %
18.17%
Holding
983
New
73
Increased
476
Reduced
281
Closed
45

Sector Composition

Rank Sector Weight
1 Technology 12.61%
2 Financials 11.67%
3 Healthcare 10.28%
4 Consumer Staples 8.64%
5 Industrials 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EG icon
101
Everest Group
EG
$15.8B
$4.51M 0.23%
16,941
+106
+0.6% +$26.8K
VFC icon
102
VF Corp
VFC
$7.16B
$4.4M 0.23%
49,479
+305
+0.6% +$26.1K
BMY icon
103
Bristol-Myers Squibb
BMY
$130B
$4.38M 0.23%
86,422
-439
-0.5% -$20.6K
PEG icon
104
Public Service Enterprise Group
PEG
$39.3B
$4.3M 0.22%
69,243
-2,621
-4% -$157K
JNK icon
105
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.06B
$4.11M 0.21%
37,821
+884
+2% +$95.8K
IGIB icon
106
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$4.1M 0.21%
70,750
+2,043
+3% +$117K
HEDJ icon
107
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.83B
$4.09M 0.21%
121,472
+1,204
+1% +$39.6K
AVGO icon
108
Broadcom
AVGO
$1.81T
$4M 0.21%
144,730
+12,940
+10% +$368K
EPD icon
109
Enterprise Products Partners
EPD
$83.6B
$3.96M 0.2%
138,413
+3,286
+2% +$95.7K
VTEB icon
110
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.3B
$3.91M 0.2%
72,852
-852
-1% -$45.6K
MDLZ icon
111
Mondelez International
MDLZ
$80.2B
$3.86M 0.2%
69,762
+8,294
+13% +$454K
VO icon
112
Vanguard Mid-Cap ETF
VO
$107B
$3.78M 0.19%
90,164
-1,796
-2% -$75K
VTI icon
113
Vanguard Total Stock Market ETF
VTI
$656B
$3.71M 0.19%
24,588
+182
+0.7% +$27.4K
GD icon
114
General Dynamics
GD
$106B
$3.66M 0.19%
20,049
-336
-2% -$62.4K
TMO icon
115
Thermo Fisher Scientific
TMO
$214B
$3.64M 0.19%
12,482
+1,140
+10% +$326K
WBA
116
DELISTED
Walgreens Boots Alliance
WBA
$3.62M 0.19%
65,357
+25,576
+64% +$1.37M
GSK icon
117
GSK
GSK
$108B
$3.58M 0.18%
67,062
+1,804
+3% +$92.8K
HYG icon
118
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$3.56M 0.18%
40,819
-541
-1% -$47K
COST icon
119
Costco
COST
$429B
$3.52M 0.18%
12,203
+154
+1% +$43.3K
VB icon
120
Vanguard Small-Cap ETF
VB
$80.2B
$3.5M 0.18%
22,751
-82
-0.4% -$12.7K
IWR icon
121
iShares Russell Mid-Cap ETF
IWR
$56.5B
$3.45M 0.18%
61,669
+14,229
+30% +$795K
VIG icon
122
Vanguard Dividend Appreciation ETF
VIG
$113B
$3.38M 0.17%
28,255
-3,944
-12% -$465K
ETN icon
123
Eaton
ETN
$150B
$3.37M 0.17%
40,515
+4,145
+11% +$336K
WELL icon
124
Welltower
WELL
$175B
$3.37M 0.17%
37,162
-1,874
-5% -$163K
NVS icon
125
Novartis
NVS
$304B
$3.33M 0.17%
38,370
-15,649
-29% -$1.41M

Similar funds

Raymond James Trust's Q3 2019 Portfolio in Review

As of Q3 2019, Raymond James Trust held 983 positions worth $1.94B, up 6.8% from $1.82B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James Trust deployed $90M of net new capital in Q3 2019, opening 73 new positions and adding to 476 existing holdings. Its largest new stake was Fulgent Genetics: 500,000 shares worth $5.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Automatic Data Processing, an estimated $2.94M trimmed.

  • Raymond James Trust's largest Q3 2019 buy was Fulgent Genetics: 500,000 shares worth $5.2M.
  • Raymond James Trust added most to iShares Core MSCI EAFE ETF in Q3 2019, an estimated $3.88M increase.
  • Raymond James Trust's biggest Q3 2019 reduction was Automatic Data Processing, cutting an estimated $2.94M.
  • Raymond James Trust fully exited Anadarko Petroleum in Q3 2019, selling an estimated $802K.
  • Raymond James Trust's ten largest holdings make up 18% of its $1.94B portfolio in Q3 2019.
  • Raymond James Trust opened 73 new positions and closed 45 in Q3 2019.
  • Raymond James Trust's portfolio value rose 6.8% quarter-over-quarter to $1.94B.

Based on Raymond James Trust's 13F filing for Q3 2019, filed 24 Oct 2019.